Coordinatore | HELMHOLTZ-ZENTRUM GEESTHACHT ZENTRUM FUR MATERIAL- UND KUSTENFORSCHUNG GMBH
Organization address
address: Max-Planck-Strasse 1 contact info |
Nazionalità Coordinatore | Germany [DE] |
Totale costo | 3˙129˙777 € |
EC contributo | 3˙129˙777 € |
Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
Code Call | FP7-PEOPLE-2011-ITN |
Funding Scheme | MC-ITN |
Anno di inizio | 2011 |
Periodo (anno-mese-giorno) | 2011-10-01 - 2015-09-30 |
# | ||||
---|---|---|---|---|
1 |
HELMHOLTZ-ZENTRUM GEESTHACHT ZENTRUM FUR MATERIAL- UND KUSTENFORSCHUNG GMBH
Organization address
address: Max-Planck-Strasse 1 contact info |
DE (GEESTHACHT) | coordinator | 900˙405.00 |
2 |
Medizinische Universitaet Graz
Organization address
address: AUENBRUGGERPLATZ 2 contact info |
AT (GRAZ) | participant | 769˙260.20 |
3 |
MALMOE HOEGSKOLA (MALMOE UNIVERSITY)
Organization address
address: HJALMAREGATAN contact info |
SE (MALMOE) | participant | 502˙674.97 |
4 |
KATHOLIEKE UNIVERSITEIT LEUVEN
Organization address
address: Oude Markt 13 contact info |
BE (LEUVEN) | participant | 493˙106.12 |
5 |
AAP BIOMATERIALS GMBH
Organization address
address: LAGERSTRASSE 11-15 contact info |
DE (DIEBURG) | participant | 240˙631.34 |
6 |
UNIVERZITA KARLOVA V PRAZE
Organization address
address: Ovocny trh 5 contact info |
CZ (PRAHA 1) | participant | 223˙700.40 |
7 |
ConMed Linvatec Biomaterials OY
Organization address
address: Hermiankatu 6-8 L contact info |
FI (Tampere) | participant | 0.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Cost reduction and improvement of the quality of life is a major issue in health care. This challenge can be tackled by intelligent biomaterials and smart implants which are resorbed by the body upon remodelling of the tissue: What is possible for polymer materials should also be realized for biodegradable metallic materials. MagnIM will train 12 ESRs to contribute to this demanding aims by the development of new aluminium free Magnesium implant materials with tailored properties specific for a bone related application especially in children and for sport medicine. To reach this goal carefully selected materials and processing routes will be combined with comprehensive research to elucidate the correlation between microstructure and corrosion processes. This will be monitored in vitro and in vivo. The ultimate goal will be a prototype implant design which is based on the achievements of this network. To do this, the specific combination of the MagnIM research team is necessary. MagnIM brings together world leading scientists from various research fields: Material scientists and engineers who develop new alloys with tailored properties for biomedical applications and medical scientists and biologists researching on macro- and microscopically changes in bones and bone cells with in vitro and in vivo methods. MagnIM collectively covers basically all aspects, instrumental techniques and approaches necessary to tackle successfully the challenge to understand, and ultimately control, interactions at the material – bone interface. The full achievements of this research are gained because the consortium covers the full value chain from fundamental engineering research towards implant production including relevant industry partners and clinics.'
The constant evolution of medical procedures poses a challenge to materials science researchers to provide novel biodegradable options. European researchers are exploiting magnesium (Mg)-based materials for use in fracture fixation.